Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 25Active not recruiting 15Not yet recruiting 3Withdrawn 2Terminated 1Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 12Breast 9Genitourinary 7Thoracic 5CNS 4Sarcoma 3Plasma cell 3Other hematologic neoplasm 3Lymphoid 3Dermatologic 3Myeloid 2Tumor-Agnostic 1Other solid neoplasm 1Head & Neck 1Gynecologic 1Classical hematology 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1

Interventions

Cisplatin 57pembrolizumab 54Cetuximab 43Radiotherapy 35Docetaxel 21Radiotherapy, Intensity-Modulated 20Paclitaxel 19Nivolumab 18Fluorouracil 18Carboplatin 17Radiation 14Radiosurgery 9Magnetic Resonance Spectroscopy 8Gemcitabine 8Everolimus 8Biopsy 8Surgical Procedures, Operative 7Oxaliplatin 7Cyclophosphamide 7durvalumab 6avelumab 6Erlotinib Hydrochloride 6Capecitabine 6spartalizumab 5epacadostat 5Surveys and Questionnaires 5Platinum 5Immunoglobulin G 5Gefitinib 5Dexamethasone 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Specimen Handling × Head & Neck × Clear all
NCT06338657 2025-09-16

FID-007 Followed by Standard of Care Surgery in Head and Neck Cancer

University of Southern California

Phase 1 Terminated
1 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck

Data powered by HemOnc (CC BY 4.0) Colophon âš¡